PK10571 (GB002)

PK10571 · GB002, Inc., a subsidiary of Gossamer Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PK10571 (GB002), covering 2020-02-17 to 2020-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1A Safety Trial of Inhaled PK10571 (GB002) [Phase 1]